Main group 1

Mandatory reading material

• Talbot, J. C. C.; Aronson, Jeffrey K.; Stephens, M. D. B., Stephens' detection and evaluation of adverse drug reactions: principles and practice, 6th ed., Chichester, West Sussex, UK, John Wiley & Sons, 2012Compulsory*
• Thao Doan, Pharmacovigilance: A Practical Approach, Elsevier, 2019Compulsory*

supplementary textbooks

• Andrews, Elizabeth B.; Moore, Nicholas, Mann's pharmacovigilance, Third edition., Chichester, West Sussex, UK, John Wiley & Sons Inc., 2014
• Cobert, Barton L., Cobert's manual of drug safety and pharmacovigilance, 2nd ed., Sudbury, Mass., Jones & Bartlett Learning, c2012
• Klepper, Michael J.; Cobert, Barton L., Drug safety data: how to analyze, summarize, and interpret to determine risk, 1st ed., Sudbury, MA, Jones and Bartlett Publishers, c2011
• Leong, James.; Salek, Sam.; Walker, Stuart., Benefit-Risk Assessment of Medicines: The Development and Application of a Universal Framework for Decision-Making and Effective Communication, Cham, Springer International Publishing, 2015

* Compulsory